HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Highest European Court Rules CBD Is Not A Narcotic Drug

Executive Summary

The European Court of Justice rules that CBD cannot be regarded as a narcotic as it is non-psychoactive and suggests that a French ban on the cannabinoid is contrary to EU law on the free movement of goods. Legal experts and industry hope the judgment will pave the way for a regulated European CBD market.

You may also be interested in...



Italy’s CBD Narcotic Reclassification Temporarily Suspended By Court

An Italian administrative court has suspended the recent reclassification of CBD as a narcotic until 24 October, when it will look at the matter more closely. 

Italy Reclassifies Natural CBD Oil As Medicine Containing Narcotic

Italy reclassifies natural CBD as a narcotic drug. The decision may see challenges from companies marketing in Italy natural CBD supplements registered in other European countries, given that the European Court of Justice (CJEU) overturned a similar position taken by France in 2020.  

Sale Of CBD Flower And Leaf Up To 0.3% THC Legal, French High Court Decides

Having no psychotropic effect and not causing addiction, CBD flowers and leaves cannot be considered a narcotic, the French high court rules, delivering its final verdict on last year's ban by the country's Ministry of Solidarity and Health. 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150728

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel